Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFIX
|
ENSG00000008441.12 | nuclear factor I X |
NFIB
|
ENSG00000147862.10 | nuclear factor I B |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_14096707_14097036 | NFIB | 83920 | 0.111989 | 0.96 | 3.7e-05 | Click! |
chr9_14096297_14096607 | NFIB | 84339 | 0.111268 | 0.94 | 1.5e-04 | Click! |
chr9_14309575_14309740 | NFIB | 1645 | 0.458203 | 0.93 | 2.2e-04 | Click! |
chr9_14251177_14251439 | NFIB | 56704 | 0.153396 | 0.93 | 2.3e-04 | Click! |
chr9_14312403_14312554 | NFIB | 1188 | 0.558006 | 0.91 | 6.4e-04 | Click! |
chr19_13135354_13135619 | NFIX | 45 | 0.951685 | 0.90 | 8.5e-04 | Click! |
chr19_13135793_13135990 | NFIX | 80 | 0.943717 | 0.89 | 1.4e-03 | Click! |
chr19_13135028_13135217 | NFIX | 272 | 0.835446 | 0.88 | 1.5e-03 | Click! |
chr19_13137554_13137705 | NFIX | 1818 | 0.202683 | 0.87 | 2.0e-03 | Click! |
chr19_13136060_13136211 | NFIX | 324 | 0.795470 | 0.87 | 2.3e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_158113918_158114875 | 5.04 |
GALNT5 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
286 |
0.93 |
chr16_4366907_4367444 | 4.33 |
GLIS2 |
GLIS family zinc finger 2 |
2413 |
0.21 |
chr15_51633704_51634417 | 4.30 |
GLDN |
gliomedin |
234 |
0.91 |
chr17_70587270_70588900 | 4.12 |
ENSG00000200783 |
. |
72206 |
0.12 |
chr4_157891142_157892336 | 4.10 |
PDGFC |
platelet derived growth factor C |
316 |
0.91 |
chr9_104248314_104249564 | 4.08 |
TMEM246 |
transmembrane protein 246 |
460 |
0.79 |
chr7_134464463_134465343 | 4.07 |
CALD1 |
caldesmon 1 |
474 |
0.89 |
chr3_48631948_48632718 | 4.07 |
COL7A1 |
collagen, type VII, alpha 1 |
260 |
0.83 |
chr8_69242814_69243988 | 3.87 |
C8orf34 |
chromosome 8 open reading frame 34 |
56 |
0.82 |
chr4_148402515_148403207 | 3.72 |
EDNRA |
endothelin receptor type A |
777 |
0.76 |
chr7_41740779_41741576 | 3.66 |
INHBA |
inhibin, beta A |
970 |
0.56 |
chr16_55513844_55514378 | 3.66 |
MMP2 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
201 |
0.95 |
chr13_93879365_93880233 | 3.63 |
GPC6 |
glypican 6 |
704 |
0.82 |
chr9_129884150_129884930 | 3.58 |
ANGPTL2 |
angiopoietin-like 2 |
373 |
0.9 |
chr12_72667295_72667865 | 3.49 |
TRHDE |
thyrotropin-releasing hormone degrading enzyme |
317 |
0.85 |
chr6_169652381_169652976 | 3.38 |
THBS2 |
thrombospondin 2 |
432 |
0.89 |
chr22_19973614_19974692 | 3.30 |
ARVCF |
armadillo repeat gene deleted in velocardiofacial syndrome |
463 |
0.71 |
chr9_684288_685148 | 3.26 |
RP11-130C19.3 |
|
837 |
0.67 |
chr4_184797459_184798247 | 3.26 |
STOX2 |
storkhead box 2 |
28656 |
0.22 |
chr12_78334342_78334902 | 3.26 |
NAV3 |
neuron navigator 3 |
25434 |
0.27 |
chr20_34025363_34025770 | 3.21 |
GDF5 |
growth differentiation factor 5 |
457 |
0.71 |
chr5_63461313_63462499 | 3.19 |
RNF180 |
ring finger protein 180 |
83 |
0.99 |
chr14_23776071_23776801 | 3.17 |
BCL2L2-PABPN1 |
BCL2L2-PABPN1 readthrough |
260 |
0.45 |
chr8_142289533_142290316 | 3.11 |
RP11-10J21.3 |
Uncharacterized protein |
25260 |
0.12 |
chr5_131594297_131594770 | 3.08 |
PDLIM4 |
PDZ and LIM domain 4 |
1133 |
0.45 |
chr14_61123462_61124719 | 2.98 |
SIX1 |
SIX homeobox 1 |
887 |
0.64 |
chr19_676845_677141 | 2.97 |
FSTL3 |
follistatin-like 3 (secreted glycoprotein) |
601 |
0.56 |
chr7_140016131_140016502 | 2.97 |
SLC37A3 |
solute carrier family 37, member 3 |
26973 |
0.14 |
chr11_119292436_119293234 | 2.95 |
THY1 |
Thy-1 cell surface antigen |
437 |
0.74 |
chr5_172754207_172754714 | 2.93 |
STC2 |
stanniocalcin 2 |
596 |
0.75 |
chr8_25042452_25043634 | 2.91 |
DOCK5 |
dedicator of cytokinesis 5 |
663 |
0.75 |
chr2_159825200_159826543 | 2.90 |
TANC1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
688 |
0.73 |
chr7_143579813_143580255 | 2.90 |
FAM115A |
family with sequence similarity 115, member A |
36 |
0.98 |
chr6_78172796_78173983 | 2.90 |
HTR1B |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
101 |
0.99 |
chr5_141703297_141704624 | 2.87 |
SPRY4 |
sprouty homolog 4 (Drosophila) |
213 |
0.88 |
chr4_157890038_157890662 | 2.86 |
PDGFC |
platelet derived growth factor C |
1705 |
0.41 |
chr2_27301899_27302732 | 2.82 |
EMILIN1 |
elastin microfibril interfacer 1 |
880 |
0.32 |
chr5_31193803_31195028 | 2.81 |
CDH6 |
cadherin 6, type 2, K-cadherin (fetal kidney) |
558 |
0.85 |
chr15_40530958_40531718 | 2.81 |
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
46 |
0.96 |
chr2_9348603_9349207 | 2.78 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
2011 |
0.46 |
chr9_140500205_140501463 | 2.77 |
ARRDC1 |
arrestin domain containing 1 |
679 |
0.56 |
chr17_75316367_75316959 | 2.75 |
SEPT9 |
septin 9 |
268 |
0.93 |
chrX_110038687_110039773 | 2.72 |
CHRDL1 |
chordin-like 1 |
56 |
0.99 |
chr5_131562588_131563831 | 2.71 |
P4HA2 |
prolyl 4-hydroxylase, alpha polypeptide II |
138 |
0.96 |
chr6_75913619_75913933 | 2.70 |
COL12A1 |
collagen, type XII, alpha 1 |
1268 |
0.52 |
chr3_8809480_8810320 | 2.67 |
OXTR |
oxytocin receptor |
463 |
0.76 |
chr11_66102741_66104078 | 2.67 |
RIN1 |
Ras and Rab interactor 1 |
468 |
0.53 |
chr15_40395062_40395658 | 2.66 |
BMF |
Bcl2 modifying factor |
2927 |
0.21 |
chr12_59313444_59313663 | 2.65 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
226 |
0.87 |
chr2_180726238_180726902 | 2.65 |
ZNF385B |
zinc finger protein 385B |
338 |
0.8 |
chr12_53443889_53444561 | 2.61 |
TENC1 |
tensin like C1 domain containing phosphatase (tensin 2) |
255 |
0.86 |
chr15_33011176_33011666 | 2.61 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
1216 |
0.49 |
chr5_58571069_58571855 | 2.61 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
483 |
0.9 |
chr6_56111778_56112295 | 2.60 |
COL21A1 |
collagen, type XXI, alpha 1 |
199 |
0.97 |
chr10_35102956_35103650 | 2.58 |
PARD3 |
par-3 family cell polarity regulator |
946 |
0.5 |
chr17_48366854_48367409 | 2.58 |
RP11-893F2.9 |
|
1915 |
0.24 |
chr1_17867048_17867282 | 2.58 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
835 |
0.7 |
chr5_150020318_150020945 | 2.57 |
SYNPO |
synaptopodin |
391 |
0.81 |
chr1_14924992_14926197 | 2.57 |
KAZN |
kazrin, periplakin interacting protein |
381 |
0.93 |
chr2_38303069_38303895 | 2.54 |
CYP1B1-AS1 |
CYP1B1 antisense RNA 1 |
156 |
0.5 |
chr9_132514889_132515259 | 2.54 |
PTGES |
prostaglandin E synthase |
252 |
0.91 |
chr21_38071900_38072434 | 2.52 |
SIM2 |
single-minded family bHLH transcription factor 2 |
176 |
0.94 |
chr12_118626563_118627015 | 2.47 |
TAOK3 |
TAO kinase 3 |
1538 |
0.42 |
chr9_140093629_140094566 | 2.47 |
TPRN |
taperin |
460 |
0.53 |
chr10_49812568_49813319 | 2.46 |
ARHGAP22 |
Rho GTPase activating protein 22 |
54 |
0.98 |
chr10_124222527_124222791 | 2.46 |
HTRA1 |
HtrA serine peptidase 1 |
1618 |
0.37 |
chr18_52626293_52626952 | 2.45 |
CCDC68 |
coiled-coil domain containing 68 |
117 |
0.97 |
chr9_139239711_139240188 | 2.44 |
GPSM1 |
G-protein signaling modulator 1 |
7560 |
0.12 |
chr1_33207592_33208218 | 2.44 |
KIAA1522 |
KIAA1522 |
419 |
0.8 |
chr19_13107353_13108160 | 2.44 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
1104 |
0.3 |
chr1_201915320_201915636 | 2.44 |
LMOD1 |
leiomodin 1 (smooth muscle) |
237 |
0.87 |
chr9_130329685_130329934 | 2.42 |
FAM129B |
family with sequence similarity 129, member B |
1558 |
0.37 |
chr3_192126971_192127690 | 2.41 |
FGF12 |
fibroblast growth factor 12 |
492 |
0.87 |
chrX_53310382_53310778 | 2.40 |
IQSEC2 |
IQ motif and Sec7 domain 2 |
216 |
0.94 |
chr4_1035336_1035962 | 2.40 |
FGFRL1 |
fibroblast growth factor receptor-like 1 |
29410 |
0.11 |
chr11_111606115_111606547 | 2.39 |
PPP2R1B |
protein phosphatase 2, regulatory subunit A, beta |
19431 |
0.17 |
chr14_75077048_75077347 | 2.38 |
LTBP2 |
latent transforming growth factor beta binding protein 2 |
1578 |
0.4 |
chr1_201436884_201437966 | 2.38 |
PHLDA3 |
pleckstrin homology-like domain, family A, member 3 |
887 |
0.55 |
chr1_99729766_99730318 | 2.38 |
LPPR4 |
Lipid phosphate phosphatase-related protein type 4 |
194 |
0.97 |
chr7_136555280_136555665 | 2.37 |
CHRM2 |
cholinergic receptor, muscarinic 2 |
1603 |
0.4 |
chr4_57276019_57276511 | 2.37 |
AC068620.1 |
Uncharacterized protein |
417 |
0.79 |
chr19_7953693_7954073 | 2.36 |
LRRC8E |
leucine rich repeat containing 8 family, member E |
447 |
0.57 |
chr22_34315378_34316336 | 2.34 |
LARGE |
like-glycosyltransferase |
469 |
0.83 |
chr7_94537689_94537929 | 2.33 |
PPP1R9A |
protein phosphatase 1, regulatory subunit 9A |
218 |
0.96 |
chr19_55684291_55685412 | 2.33 |
SYT5 |
synaptotagmin V |
1083 |
0.28 |
chr19_41195400_41196566 | 2.33 |
NUMBL |
numb homolog (Drosophila)-like |
44 |
0.96 |
chr2_164592268_164592669 | 2.32 |
FIGN |
fidgetin |
49 |
0.99 |
chr2_142887906_142888379 | 2.29 |
LRP1B |
low density lipoprotein receptor-related protein 1B |
432 |
0.87 |
chr18_11149170_11149978 | 2.28 |
PIEZO2 |
piezo-type mechanosensitive ion channel component 2 |
987 |
0.72 |
chr17_34611752_34612896 | 2.27 |
CCL3L1 |
chemokine (C-C motif) ligand 3-like 1 |
13395 |
0.14 |
chr1_217262846_217263329 | 2.26 |
ESRRG |
estrogen-related receptor gamma |
111 |
0.98 |
chr13_30002091_30002575 | 2.25 |
MTUS2 |
microtubule associated tumor suppressor candidate 2 |
431 |
0.89 |
chr3_129407054_129407730 | 2.24 |
TMCC1 |
transmembrane and coiled-coil domain family 1 |
183 |
0.96 |
chr16_2517636_2518674 | 2.24 |
RP11-715J22.2 |
|
59 |
0.92 |
chr6_137310724_137311134 | 2.23 |
RP11-204P2.3 |
|
5378 |
0.23 |
chr7_5466974_5467725 | 2.23 |
TNRC18 |
trinucleotide repeat containing 18 |
2304 |
0.22 |
chr5_178368250_178368762 | 2.23 |
ZNF454 |
zinc finger protein 454 |
282 |
0.89 |
chr20_31062740_31063476 | 2.22 |
C20orf112 |
chromosome 20 open reading frame 112 |
8166 |
0.18 |
chr19_56728415_56729241 | 2.22 |
ZSCAN5A |
zinc finger and SCAN domain containing 5A |
10831 |
0.1 |
chr11_86382517_86383664 | 2.22 |
ME3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
150 |
0.98 |
chr9_21688149_21688723 | 2.20 |
ENSG00000244230 |
. |
10877 |
0.24 |
chr6_161649839_161650239 | 2.20 |
AGPAT4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
45012 |
0.2 |
chr1_36549458_36550287 | 2.20 |
TEKT2 |
tektin 2 (testicular) |
196 |
0.92 |
chr1_204386380_204386632 | 2.19 |
PPP1R15B |
protein phosphatase 1, regulatory subunit 15B |
5587 |
0.2 |
chr1_205512841_205513165 | 2.19 |
ENSG00000253097 |
. |
22841 |
0.13 |
chr17_69971611_69971805 | 2.19 |
AC007461.1 |
Uncharacterized protein |
64456 |
0.15 |
chrX_153601896_153602918 | 2.19 |
FLNA |
filamin A, alpha |
587 |
0.54 |
chr15_68871678_68872325 | 2.19 |
CORO2B |
coronin, actin binding protein, 2B |
428 |
0.9 |
chr5_32713757_32714054 | 2.19 |
NPR3 |
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
1468 |
0.51 |
chr15_72529055_72529849 | 2.18 |
PKM |
pyruvate kinase, muscle |
5288 |
0.17 |
chr3_173302672_173303490 | 2.18 |
NLGN1 |
neuroligin 1 |
371 |
0.93 |
chr9_130330127_130331202 | 2.18 |
FAM129B |
family with sequence similarity 129, member B |
703 |
0.67 |
chr17_1665908_1666244 | 2.17 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
47 |
0.96 |
chr2_9396815_9397226 | 2.16 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
50126 |
0.17 |
chr9_85677185_85677712 | 2.16 |
RASEF |
RAS and EF-hand domain containing |
595 |
0.84 |
chr2_113956230_113956830 | 2.16 |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
2673 |
0.2 |
chrX_105969921_105970262 | 2.16 |
RNF128 |
ring finger protein 128, E3 ubiquitin protein ligase |
197 |
0.96 |
chr6_28442401_28443147 | 2.15 |
ZSCAN23 |
zinc finger and SCAN domain containing 23 |
31530 |
0.13 |
chr4_75718841_75720131 | 2.15 |
BTC |
betacellulin |
410 |
0.91 |
chr11_94134107_94135010 | 2.15 |
GPR83 |
G protein-coupled receptor 83 |
0 |
0.98 |
chr10_24757295_24757469 | 2.14 |
KIAA1217 |
KIAA1217 |
1922 |
0.4 |
chr11_120195755_120196855 | 2.13 |
TMEM136 |
transmembrane protein 136 |
289 |
0.9 |
chr9_25677269_25678110 | 2.13 |
TUSC1 |
tumor suppressor candidate 1 |
1167 |
0.68 |
chr16_65566073_65566543 | 2.12 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
410040 |
0.01 |
chr2_241949003_241950045 | 2.11 |
AC093585.6 |
|
637 |
0.62 |
chr2_228028292_228028853 | 2.11 |
COL4A4 |
collagen, type IV, alpha 4 |
257 |
0.8 |
chr9_116356336_116356765 | 2.10 |
RGS3 |
regulator of G-protein signaling 3 |
784 |
0.67 |
chr11_126862327_126862775 | 2.09 |
RP11-688I9.2 |
|
203 |
0.92 |
chr18_43732416_43732901 | 2.09 |
C18orf25 |
chromosome 18 open reading frame 25 |
20861 |
0.15 |
chr6_72892413_72892934 | 2.08 |
RIMS1 |
regulating synaptic membrane exocytosis 1 |
218 |
0.96 |
chr15_39871853_39872515 | 2.08 |
THBS1 |
thrombospondin 1 |
1096 |
0.52 |
chr3_134046066_134046593 | 2.08 |
AMOTL2 |
angiomotin like 2 |
44425 |
0.15 |
chr11_118492062_118492969 | 2.07 |
PHLDB1 |
pleckstrin homology-like domain, family B, member 1 |
14157 |
0.11 |
chr11_1897889_1898478 | 2.06 |
LSP1 |
lymphocyte-specific protein 1 |
476 |
0.66 |
chr9_35489468_35490886 | 2.05 |
RUSC2 |
RUN and SH3 domain containing 2 |
53 |
0.97 |
chr10_17390339_17390851 | 2.04 |
ST8SIA6 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 |
21487 |
0.18 |
chr3_157260663_157261197 | 2.03 |
C3orf55 |
chromosome 3 open reading frame 55 |
105 |
0.98 |
chr9_40632604_40633916 | 2.02 |
SPATA31A3 |
SPATA31 subfamily A, member 3 |
67031 |
0.14 |
chr12_13351879_13352395 | 2.02 |
EMP1 |
epithelial membrane protein 1 |
2417 |
0.37 |
chr8_121137253_121137925 | 2.02 |
COL14A1 |
collagen, type XIV, alpha 1 |
237 |
0.96 |
chr19_782291_783217 | 2.01 |
PTBP1 |
polypyrimidine tract binding protein 1 |
14321 |
0.09 |
chr5_92918344_92919004 | 2.01 |
NR2F1 |
nuclear receptor subfamily 2, group F, member 1 |
369 |
0.84 |
chr16_4422135_4423224 | 2.01 |
VASN |
vasorin |
830 |
0.49 |
chr9_110250307_110251795 | 2.00 |
KLF4 |
Kruppel-like factor 4 (gut) |
360 |
0.89 |
chr16_88450130_88450579 | 2.00 |
ZNF469 |
zinc finger protein 469 |
43525 |
0.15 |
chr1_214397865_214398571 | 2.00 |
SMYD2 |
SET and MYND domain containing 2 |
56358 |
0.16 |
chr11_77733968_77734525 | 2.00 |
KCTD14 |
potassium channel tetramerization domain containing 14 |
94 |
0.72 |
chr13_38444003_38444421 | 1.97 |
TRPC4 |
transient receptor potential cation channel, subfamily C, member 4 |
273 |
0.94 |
chr17_27043546_27044298 | 1.96 |
RAB34 |
RAB34, member RAS oncogene family |
844 |
0.24 |
chr15_39873424_39874712 | 1.96 |
THBS1 |
thrombospondin 1 |
774 |
0.66 |
chr3_61546098_61546562 | 1.95 |
PTPRG |
protein tyrosine phosphatase, receptor type, G |
1255 |
0.64 |
chr14_85999097_85999705 | 1.94 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
2829 |
0.32 |
chr11_27740485_27740934 | 1.94 |
BDNF |
brain-derived neurotrophic factor |
585 |
0.82 |
chr7_41739624_41740047 | 1.94 |
INHBA |
inhibin, beta A |
372 |
0.87 |
chr19_10736478_10736985 | 1.94 |
SLC44A2 |
solute carrier family 44 (choline transporter), member 2 |
530 |
0.65 |
chr7_119913514_119913995 | 1.91 |
KCND2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
32 |
0.99 |
chr2_75787048_75787447 | 1.90 |
EVA1A |
eva-1 homolog A (C. elegans) |
792 |
0.61 |
chr11_33714223_33714589 | 1.90 |
RP4-541C22.5 |
|
3841 |
0.2 |
chr3_157154723_157155399 | 1.89 |
PTX3 |
pentraxin 3, long |
483 |
0.86 |
chr6_119069398_119069957 | 1.88 |
CEP85L |
centrosomal protein 85kDa-like |
38439 |
0.19 |
chr17_15166292_15166618 | 1.88 |
PMP22 |
peripheral myelin protein 22 |
549 |
0.68 |
chr14_81015419_81015845 | 1.88 |
CEP128 |
centrosomal protein 128kDa |
31137 |
0.25 |
chr9_71939475_71940274 | 1.87 |
FAM189A2 |
family with sequence similarity 189, member A2 |
386 |
0.91 |
chr9_130860266_130860759 | 1.87 |
SLC25A25 |
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
71 |
0.93 |
chr8_55294582_55295235 | 1.86 |
ENSG00000244107 |
. |
38120 |
0.17 |
chr12_43945597_43946279 | 1.86 |
ADAMTS20 |
ADAM metallopeptidase with thrombospondin type 1 motif, 20 |
214 |
0.97 |
chr1_170633420_170634117 | 1.86 |
PRRX1 |
paired related homeobox 1 |
690 |
0.8 |
chr10_15411519_15412658 | 1.86 |
FAM171A1 |
family with sequence similarity 171, member A1 |
970 |
0.7 |
chr17_74864002_74864361 | 1.85 |
MGAT5B |
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B |
357 |
0.88 |
chr12_88973452_88974158 | 1.85 |
KITLG |
KIT ligand |
433 |
0.82 |
chr22_18051179_18051572 | 1.84 |
SLC25A18 |
solute carrier family 25 (glutamate carrier), member 18 |
8225 |
0.18 |
chr5_98397075_98397538 | 1.84 |
ENSG00000200351 |
. |
124855 |
0.06 |
chr2_121493751_121494304 | 1.84 |
GLI2 |
GLI family zinc finger 2 |
204 |
0.97 |
chr15_69366192_69366980 | 1.83 |
RP11-809H16.4 |
|
30681 |
0.17 |
chr2_33361191_33361342 | 1.83 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
1542 |
0.54 |
chr9_109459969_109460612 | 1.83 |
ENSG00000200131 |
. |
18032 |
0.28 |
chr11_2847450_2848020 | 1.82 |
KCNQ1-AS1 |
KCNQ1 antisense RNA 1 |
35063 |
0.12 |
chr15_96877000_96877175 | 1.82 |
ENSG00000222651 |
. |
597 |
0.47 |
chr4_41363336_41363659 | 1.82 |
LIMCH1 |
LIM and calponin homology domains 1 |
665 |
0.77 |
chr15_37175433_37176047 | 1.82 |
ENSG00000212511 |
. |
30899 |
0.23 |
chr2_168148837_168149519 | 1.82 |
XIRP2 |
xin actin-binding repeat containing 2 |
105385 |
0.08 |
chr12_59311038_59311457 | 1.81 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2080 |
0.36 |
chr7_80547175_80548098 | 1.81 |
SEMA3C |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
863 |
0.76 |
chr8_86350363_86351282 | 1.81 |
CA3 |
carbonic anhydrase III, muscle specific |
234 |
0.93 |
chr16_54970178_54971110 | 1.81 |
IRX5 |
iroquois homeobox 5 |
4660 |
0.36 |
chr10_76684287_76684702 | 1.81 |
KAT6B |
K(lysine) acetyltransferase 6B |
86036 |
0.08 |
chr15_90205872_90206267 | 1.80 |
PLIN1 |
perilipin 1 |
4802 |
0.14 |
chr17_13504603_13505279 | 1.80 |
HS3ST3A1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
303 |
0.94 |
chr16_70221940_70222878 | 1.80 |
CLEC18C |
C-type lectin domain family 18, member C |
14349 |
0.1 |
chr11_65664383_65664636 | 1.80 |
FOSL1 |
FOS-like antigen 1 |
3381 |
0.1 |
chr11_113649028_113649338 | 1.80 |
CLDN25 |
claudin 25 |
1286 |
0.35 |
chr9_16726683_16727481 | 1.80 |
RP11-62F24.2 |
|
270 |
0.85 |
chr15_66209126_66209488 | 1.80 |
RAB11A |
RAB11A, member RAS oncogene family |
46956 |
0.13 |
chr21_33893367_33893849 | 1.80 |
ENSG00000252045 |
. |
17001 |
0.16 |
chr9_35688355_35688710 | 1.79 |
TPM2 |
tropomyosin 2 (beta) |
1368 |
0.2 |
chr6_152701966_152702349 | 1.79 |
SYNE1-AS1 |
SYNE1 antisense RNA 1 |
476 |
0.79 |
chr4_169753076_169754370 | 1.79 |
RP11-635L1.3 |
|
365 |
0.61 |
chr5_178367547_178367761 | 1.78 |
ZNF454 |
zinc finger protein 454 |
538 |
0.73 |
chr7_91195255_91195601 | 1.78 |
FZD1 |
frizzled family receptor 1 |
301645 |
0.01 |
chr22_46476561_46476775 | 1.78 |
FLJ27365 |
hsa-mir-4763 |
476 |
0.66 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
2.7 | 8.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
2.7 | 8.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
2.5 | 9.8 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
2.4 | 2.4 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
2.4 | 7.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
2.2 | 6.6 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
2.2 | 8.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.1 | 6.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.9 | 7.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.9 | 5.6 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.9 | 5.6 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
1.9 | 5.6 | GO:0051451 | myoblast migration(GO:0051451) |
1.8 | 5.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.8 | 5.3 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
1.7 | 5.2 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
1.7 | 5.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
1.7 | 5.1 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
1.6 | 1.6 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
1.6 | 1.6 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
1.6 | 3.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
1.6 | 6.3 | GO:0070141 | response to UV-A(GO:0070141) |
1.6 | 3.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.5 | 4.5 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
1.5 | 7.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
1.5 | 2.9 | GO:0060433 | bronchus development(GO:0060433) |
1.4 | 2.8 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
1.4 | 4.1 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
1.3 | 5.4 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.3 | 5.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
1.3 | 2.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.3 | 2.5 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
1.2 | 8.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.2 | 2.5 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
1.2 | 2.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.2 | 2.4 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
1.2 | 27.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
1.2 | 2.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.2 | 2.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
1.2 | 6.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.1 | 2.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
1.1 | 6.7 | GO:0032288 | myelin assembly(GO:0032288) |
1.1 | 1.1 | GO:0060976 | coronary vasculature development(GO:0060976) |
1.1 | 1.1 | GO:0001945 | lymph vessel development(GO:0001945) |
1.1 | 4.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.1 | 3.2 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
1.1 | 7.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
1.1 | 1.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.1 | 1.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
1.0 | 3.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.0 | 3.1 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
1.0 | 2.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
1.0 | 2.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
1.0 | 5.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.0 | 2.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
1.0 | 1.0 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
1.0 | 4.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
1.0 | 2.0 | GO:0060437 | lung growth(GO:0060437) |
1.0 | 2.0 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
1.0 | 11.7 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
1.0 | 2.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.0 | 3.9 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
1.0 | 3.8 | GO:0008218 | bioluminescence(GO:0008218) |
1.0 | 1.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.9 | 1.9 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.9 | 2.8 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.9 | 5.7 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.9 | 2.8 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.9 | 2.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.9 | 1.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.9 | 0.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.9 | 0.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.9 | 0.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.9 | 3.5 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.9 | 2.6 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.9 | 1.7 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.9 | 2.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.8 | 0.8 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.8 | 0.8 | GO:0003207 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.8 | 0.8 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.8 | 6.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.8 | 0.8 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.8 | 2.4 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.8 | 1.6 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.8 | 2.4 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.8 | 1.6 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.8 | 2.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.8 | 3.1 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.8 | 1.6 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.8 | 2.3 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.8 | 6.2 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.8 | 2.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.8 | 1.5 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.8 | 2.3 | GO:0010662 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.7 | 4.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.7 | 0.7 | GO:0022038 | corpus callosum development(GO:0022038) |
0.7 | 1.5 | GO:0010193 | response to ozone(GO:0010193) |
0.7 | 1.5 | GO:0060596 | mammary placode formation(GO:0060596) |
0.7 | 0.7 | GO:0003079 | obsolete positive regulation of natriuresis(GO:0003079) |
0.7 | 3.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.7 | 2.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.7 | 2.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.7 | 4.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.7 | 0.7 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.7 | 1.4 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.7 | 3.5 | GO:0014850 | response to muscle activity(GO:0014850) |
0.7 | 0.7 | GO:0042663 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.7 | 2.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.7 | 2.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.7 | 2.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.7 | 2.7 | GO:0070091 | glucagon secretion(GO:0070091) |
0.7 | 0.7 | GO:0060214 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.7 | 1.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.7 | 2.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.7 | 7.3 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.7 | 2.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.7 | 0.7 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.7 | 0.7 | GO:0090030 | regulation of steroid hormone biosynthetic process(GO:0090030) |
0.7 | 0.7 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.6 | 3.9 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.6 | 0.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.6 | 8.9 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.6 | 3.8 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.6 | 1.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.6 | 1.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.6 | 0.6 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.6 | 4.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.6 | 3.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.6 | 3.6 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.6 | 1.2 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.6 | 1.8 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.6 | 3.5 | GO:0009629 | response to gravity(GO:0009629) |
0.6 | 0.6 | GO:0060435 | bronchiole development(GO:0060435) |
0.6 | 1.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 0.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.6 | 1.7 | GO:0060013 | righting reflex(GO:0060013) |
0.6 | 0.6 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.6 | 1.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.6 | 0.6 | GO:0060438 | trachea development(GO:0060438) |
0.6 | 2.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.6 | 6.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.5 | 0.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.5 | 0.5 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.5 | 1.6 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.5 | 0.5 | GO:0060346 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.5 | 2.7 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.5 | 1.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.5 | 1.6 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.5 | 1.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.5 | 1.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.5 | 0.5 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.5 | 1.6 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.5 | 1.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.5 | 3.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.5 | 1.6 | GO:0034653 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.5 | 3.6 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.5 | 0.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.5 | 1.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.5 | 3.1 | GO:0008228 | opsonization(GO:0008228) |
0.5 | 9.6 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.5 | 4.0 | GO:0008038 | neuron recognition(GO:0008038) |
0.5 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.5 | 3.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.5 | 2.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.5 | 1.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 0.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.5 | 2.4 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 1.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.5 | 1.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.5 | 0.5 | GO:0001885 | endothelial cell development(GO:0001885) |
0.5 | 1.9 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.5 | 1.4 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 0.9 | GO:0010171 | body morphogenesis(GO:0010171) |
0.5 | 0.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.5 | 1.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 1.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 0.5 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.5 | 5.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.5 | 0.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.5 | 0.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.5 | 1.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.5 | 1.8 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.5 | 2.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 1.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.4 | 1.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.4 | 4.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.4 | 0.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 2.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.4 | 1.3 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.4 | 1.3 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.4 | 2.2 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.4 | 1.7 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.4 | 3.5 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.4 | 0.4 | GO:0055083 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) monovalent inorganic anion homeostasis(GO:0055083) |
0.4 | 1.3 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.4 | 0.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.4 | 2.6 | GO:0043113 | receptor clustering(GO:0043113) |
0.4 | 1.3 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.4 | 1.7 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.4 | 1.7 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.4 | 0.8 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.4 | 1.3 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.4 | 0.8 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.4 | 2.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.4 | 2.1 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.4 | 3.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.4 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.4 | 2.4 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.4 | 9.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.4 | 1.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 3.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.4 | 0.8 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 4.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.4 | 1.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.4 | 2.8 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.4 | 7.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.4 | 1.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 2.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.4 | 1.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.4 | 1.6 | GO:0030238 | male sex determination(GO:0030238) |
0.4 | 4.4 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.4 | 1.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.4 | 49.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 1.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 0.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 1.5 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.4 | 1.5 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.4 | 0.4 | GO:0034201 | response to oleic acid(GO:0034201) |
0.4 | 2.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 1.5 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.4 | 6.8 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.4 | 2.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.4 | 1.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 0.4 | GO:0072070 | loop of Henle development(GO:0072070) |
0.4 | 0.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.4 | 6.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 0.4 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.4 | 1.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 1.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.4 | 0.7 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.4 | 2.9 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.4 | 1.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.4 | 0.7 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.4 | 1.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 1.8 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.4 | 1.1 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.4 | 0.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.4 | 1.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.4 | 1.8 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.4 | 0.4 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.4 | 1.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 1.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.3 | 1.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 1.7 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.3 | 1.4 | GO:0001660 | fever generation(GO:0001660) |
0.3 | 1.0 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.3 | 0.7 | GO:0014902 | myotube differentiation(GO:0014902) |
0.3 | 0.7 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.3 | 1.4 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.3 | 1.0 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of leukocyte apoptotic process(GO:2000108) |
0.3 | 2.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.3 | 1.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.3 | 1.0 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.3 | 0.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.3 | 1.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.3 | 4.9 | GO:0007566 | embryo implantation(GO:0007566) |
0.3 | 0.3 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.3 | 1.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 1.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.3 | 0.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 1.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.3 | 1.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.3 | 1.3 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 | 0.9 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.3 | 2.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 0.3 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.3 | 0.3 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.3 | 0.9 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.3 | 1.2 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.3 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 1.8 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.3 | 0.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 0.3 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.3 | 2.4 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.3 | 0.3 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.3 | 0.9 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.3 | 0.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.3 | 2.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.3 | 1.2 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.3 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.3 | 1.7 | GO:0001508 | action potential(GO:0001508) |
0.3 | 3.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.3 | 1.1 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.3 | 0.6 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.3 | 0.6 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) |
0.3 | 0.3 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.3 | 3.1 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.3 | 0.8 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 0.8 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.3 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 0.6 | GO:0097576 | vacuole fusion(GO:0097576) |
0.3 | 1.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 0.3 | GO:0003179 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) |
0.3 | 1.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 0.5 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.3 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 1.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.3 | 0.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 1.3 | GO:0007530 | sex determination(GO:0007530) |
0.3 | 2.1 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.3 | 0.5 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.3 | 0.8 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.3 | 0.5 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.3 | 5.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 0.8 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.3 | 0.5 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.2 | 1.5 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 0.2 | GO:0031650 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.2 | 0.7 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 1.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.9 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.2 | 0.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.5 | GO:0021546 | rhombomere development(GO:0021546) |
0.2 | 0.5 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.2 | 0.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.2 | 0.5 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 0.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 0.4 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.2 | 2.9 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
0.2 | 1.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 2.6 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 0.2 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.2 | 0.4 | GO:0048820 | hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.2 | 0.4 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.9 | GO:0051953 | negative regulation of amine transport(GO:0051953) negative regulation of amino acid transport(GO:0051956) |
0.2 | 0.4 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
0.2 | 1.3 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.2 | 0.4 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.2 | 0.2 | GO:0060039 | pericardium development(GO:0060039) |
0.2 | 0.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 2.7 | GO:0042402 | amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
0.2 | 0.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 1.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 1.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.2 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.2 | 0.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.2 | 0.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 2.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.4 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.2 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 0.6 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
0.2 | 2.4 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.2 | 2.4 | GO:0097480 | synaptic vesicle transport(GO:0048489) synaptic vesicle localization(GO:0097479) establishment of synaptic vesicle localization(GO:0097480) |
0.2 | 3.2 | GO:2000181 | negative regulation of blood vessel morphogenesis(GO:2000181) |
0.2 | 1.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.2 | 1.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.2 | 0.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 1.8 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.2 | 0.2 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.2 | 1.4 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 0.4 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 0.2 | GO:0072506 | cellular phosphate ion homeostasis(GO:0030643) phosphate ion homeostasis(GO:0055062) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.2 | 0.8 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.2 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 1.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 0.2 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.2 | 0.6 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.2 | 2.1 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.2 | 0.4 | GO:0016246 | RNA interference(GO:0016246) |
0.2 | 1.5 | GO:0007613 | memory(GO:0007613) |
0.2 | 0.9 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 0.7 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.2 | 0.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.6 | GO:0003341 | cilium movement(GO:0003341) |
0.2 | 1.1 | GO:0090280 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
0.2 | 2.0 | GO:0001657 | ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.2 | 0.4 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.2 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.4 | GO:0042220 | response to cocaine(GO:0042220) |
0.2 | 0.4 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.2 | 0.4 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.2 | 1.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 3.2 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.2 | 1.1 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.2 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.7 | GO:0030325 | adrenal gland development(GO:0030325) |
0.2 | 0.7 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.2 | 1.6 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.2 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 2.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.3 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.2 | 0.7 | GO:0030431 | sleep(GO:0030431) |
0.2 | 0.5 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 0.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 1.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 1.7 | GO:0050931 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.2 | 0.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 2.6 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.2 | 1.5 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.2 | 1.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.2 | 1.0 | GO:0032400 | melanosome localization(GO:0032400) |
0.2 | 3.2 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.2 | 1.0 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.2 | 0.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.2 | 2.5 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.5 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 3.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 0.5 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.2 | 0.2 | GO:0014904 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.2 | 0.8 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.2 | 0.8 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 2.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.6 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.2 | 1.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 0.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.6 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.2 | 3.1 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.2 | 0.6 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.2 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.2 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.2 | 0.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 2.0 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.2 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 0.2 | GO:0010656 | negative regulation of muscle cell apoptotic process(GO:0010656) |
0.1 | 0.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 3.4 | GO:0071773 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.1 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.7 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 0.4 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 1.0 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 2.5 | GO:0014020 | primary neural tube formation(GO:0014020) |
0.1 | 0.6 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 1.0 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.4 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 1.0 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.7 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 2.7 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 | 0.1 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.1 | 0.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 1.5 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 0.4 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.3 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 1.0 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.1 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.4 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.1 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 0.9 | GO:0033189 | response to vitamin A(GO:0033189) |
0.1 | 0.3 | GO:0099565 | regulation of postsynaptic membrane potential(GO:0060078) excitatory postsynaptic potential(GO:0060079) chemical synaptic transmission, postsynaptic(GO:0099565) |
0.1 | 1.3 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.1 | 0.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.5 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.3 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.4 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.5 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.1 | 0.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.3 | GO:0032109 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.1 | 0.1 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 0.5 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.4 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.5 | GO:0043650 | glutamate biosynthetic process(GO:0006537) dicarboxylic acid biosynthetic process(GO:0043650) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 1.5 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 0.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 1.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.8 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.4 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.6 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 0.4 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 12.7 | GO:0006936 | muscle contraction(GO:0006936) |
0.1 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 2.5 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.5 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 1.5 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.1 | 1.6 | GO:0051216 | cartilage development(GO:0051216) |
0.1 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 6.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 1.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.1 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.1 | 0.3 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.1 | 0.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.1 | GO:0007431 | salivary gland development(GO:0007431) |
0.1 | 0.1 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.1 | 2.7 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.3 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.5 | GO:0015904 | tetracycline transport(GO:0015904) |
0.1 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.6 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.3 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.2 | GO:0042428 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.1 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.9 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 0.3 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.5 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.2 | GO:0010269 | response to selenium ion(GO:0010269) |
0.1 | 0.1 | GO:0016265 | obsolete death(GO:0016265) |
0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 10.8 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 0.3 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.3 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.6 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
0.1 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.2 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
0.1 | 0.2 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.1 | 0.4 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.1 | 0.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 2.5 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.1 | 0.1 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
0.1 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.2 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.5 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.7 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 2.6 | GO:0044344 | cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |
0.1 | 0.1 | GO:0051588 | regulation of neurotransmitter secretion(GO:0046928) regulation of neurotransmitter transport(GO:0051588) |
0.1 | 0.6 | GO:1901070 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) guanosine-containing compound biosynthetic process(GO:1901070) |
0.1 | 0.1 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
0.1 | 0.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.2 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.1 | 0.4 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.1 | 0.1 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.5 | GO:0031103 | axon regeneration(GO:0031103) |
0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 2.6 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 4.9 | GO:0001525 | angiogenesis(GO:0001525) |
0.1 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) regulation of translational initiation in response to stress(GO:0043558) |
0.1 | 0.4 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.3 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.1 | 3.5 | GO:0008544 | epidermis development(GO:0008544) |
0.1 | 0.1 | GO:0061333 | renal tubule morphogenesis(GO:0061333) |
0.1 | 0.3 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.4 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.1 | 0.3 | GO:0021543 | pallium development(GO:0021543) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.0 | GO:0045979 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.0 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.0 | 0.7 | GO:0016358 | dendrite development(GO:0016358) |
0.0 | 0.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 2.2 | GO:0001501 | skeletal system development(GO:0001501) |
0.0 | 0.1 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.0 | GO:0032099 | regulation of appetite(GO:0032098) negative regulation of appetite(GO:0032099) |
0.0 | 0.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0090130 | tissue migration(GO:0090130) |
0.0 | 0.1 | GO:0048806 | genitalia development(GO:0048806) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0048167 | regulation of synaptic plasticity(GO:0048167) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0051133 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
0.0 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0061365 | positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.1 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.1 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.0 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0048645 | organ formation(GO:0048645) |
0.0 | 0.0 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.0 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.0 | GO:0001823 | mesonephros development(GO:0001823) |
0.0 | 0.0 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.0 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.5 | GO:0034249 | negative regulation of cellular amide metabolic process(GO:0034249) |
0.0 | 0.0 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.0 | 0.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.1 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.2 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
2.3 | 2.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
1.8 | 12.3 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
1.7 | 5.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.7 | 8.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.7 | 1.7 | GO:0043260 | laminin-11 complex(GO:0043260) |
1.6 | 1.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.3 | 6.4 | GO:0071437 | invadopodium(GO:0071437) |
1.2 | 3.5 | GO:0070852 | cell body fiber(GO:0070852) |
1.1 | 3.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
1.1 | 9.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.1 | 1.1 | GO:0031528 | microvillus membrane(GO:0031528) |
1.1 | 4.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.0 | 4.1 | GO:0043218 | compact myelin(GO:0043218) |
1.0 | 6.1 | GO:0001527 | microfibril(GO:0001527) |
1.0 | 6.7 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.0 | 8.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.9 | 7.3 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.9 | 7.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.8 | 3.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.8 | 0.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.8 | 3.0 | GO:0030673 | axolemma(GO:0030673) |
0.8 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.7 | 3.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 3.0 | GO:0005638 | lamin filament(GO:0005638) |
0.7 | 2.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 4.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.6 | 6.5 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.6 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.6 | 3.4 | GO:0010369 | chromocenter(GO:0010369) |
0.6 | 1.1 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.6 | 5.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 3.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.5 | 1.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 6.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.5 | 3.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 119.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.5 | 1.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.5 | 1.9 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.5 | 1.4 | GO:0032449 | CBM complex(GO:0032449) |
0.5 | 0.9 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.4 | 4.9 | GO:0030315 | T-tubule(GO:0030315) |
0.4 | 1.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 21.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.4 | 33.7 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.4 | 1.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.4 | 23.3 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 1.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 9.7 | GO:0030018 | Z disc(GO:0030018) |
0.4 | 9.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.4 | 5.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.4 | 0.7 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 4.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.3 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 2.0 | GO:0043034 | costamere(GO:0043034) |
0.3 | 8.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 25.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 0.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.3 | 1.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.3 | 1.8 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.3 | 4.5 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 5.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 0.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 3.2 | GO:0044447 | axoneme part(GO:0044447) |
0.2 | 1.7 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 2.5 | GO:0070161 | anchoring junction(GO:0070161) |
0.2 | 0.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 25.2 | GO:0005911 | cell-cell junction(GO:0005911) |
0.2 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.2 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.2 | 0.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 4.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 6.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 2.0 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 29.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 9.2 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.1 | 0.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 1.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 60.3 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 3.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.2 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 1.3 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 1.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.6 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.5 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.1 | 1.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 3.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 8.9 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 2.7 | GO:0030054 | cell junction(GO:0030054) |
0.1 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 3.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.6 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 2.4 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 1.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.0 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 1.5 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.7 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 1.6 | GO:0098794 | postsynapse(GO:0098794) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 1.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 2.7 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 18.8 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.0 | GO:0044216 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.2 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.4 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.7 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 10.4 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
2.4 | 7.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
2.2 | 6.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.1 | 8.4 | GO:0048495 | Roundabout binding(GO:0048495) |
1.9 | 5.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.7 | 3.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.7 | 5.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.6 | 4.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.5 | 6.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
1.4 | 4.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.4 | 4.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.4 | 8.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.4 | 8.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.3 | 5.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.3 | 3.9 | GO:0070052 | collagen V binding(GO:0070052) |
1.3 | 3.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.3 | 5.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.3 | 3.8 | GO:0003680 | AT DNA binding(GO:0003680) |
1.2 | 8.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
1.2 | 11.0 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
1.2 | 4.8 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
1.2 | 10.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.1 | 3.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.1 | 5.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.1 | 2.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
1.0 | 3.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.0 | 8.0 | GO:0017166 | vinculin binding(GO:0017166) |
1.0 | 2.9 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
1.0 | 2.9 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.9 | 3.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.9 | 2.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.8 | 3.4 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.8 | 11.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.8 | 2.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.8 | 2.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.8 | 7.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.8 | 4.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.8 | 3.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.8 | 16.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.8 | 2.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 2.3 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.8 | 2.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.8 | 3.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 2.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.8 | 3.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.7 | 4.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.7 | 3.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.7 | 10.0 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.7 | 5.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.7 | 2.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.7 | 2.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 2.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.7 | 2.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.7 | 3.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.7 | 2.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 43.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.6 | 2.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.6 | 1.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.6 | 1.9 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.6 | 1.8 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.6 | 13.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 1.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.6 | 5.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 1.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.6 | 2.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 3.5 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.6 | 4.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 3.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.6 | 1.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.6 | 1.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 9.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 2.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.5 | 0.5 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.5 | 2.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.5 | 4.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.5 | 2.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 2.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 4.7 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.5 | 9.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 2.6 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.5 | 1.5 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.5 | 1.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.5 | 2.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.5 | 2.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 1.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.5 | 7.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.5 | 0.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 4.4 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 5.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.5 | 2.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 2.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.5 | 1.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.5 | 1.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.5 | 1.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 2.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.5 | 2.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.5 | 3.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 1.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 2.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 1.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.4 | 2.6 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.4 | 0.9 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.4 | 3.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 1.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 3.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.4 | 1.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.4 | 1.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.4 | 2.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 2.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.4 | 2.7 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.4 | 1.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 2.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 1.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.4 | 1.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 1.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.4 | 1.5 | GO:0005497 | androgen binding(GO:0005497) |
0.4 | 1.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 3.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 1.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 3.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 1.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 4.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 3.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 1.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 1.7 | GO:0000036 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.3 | 0.7 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.3 | 1.7 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 1.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 1.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.3 | 4.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 36.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.3 | 1.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 1.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 2.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.3 | 0.9 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.3 | 3.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.3 | 5.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 12.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 0.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 7.1 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 0.9 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 0.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 7.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 1.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 0.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 0.9 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 1.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 2.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 4.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.3 | 0.9 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 1.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 1.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 3.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 0.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 3.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 1.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 3.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.3 | 0.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 1.3 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.3 | 0.8 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.3 | 0.8 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 1.0 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.3 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 4.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 16.9 | GO:0008201 | heparin binding(GO:0008201) |
0.3 | 2.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 2.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 0.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 3.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 1.2 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.2 | 2.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 2.4 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 2.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 64.9 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.2 | 1.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 3.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 1.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 22.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 1.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 3.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 2.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 0.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 9.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 0.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 3.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 1.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.2 | 2.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 6.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 0.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 3.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 3.6 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.2 | 1.4 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.2 | 0.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 1.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.6 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 0.6 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.2 | 1.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.9 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 2.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.2 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 2.7 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 2.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 0.9 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.2 | 0.2 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 1.4 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.2 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.6 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 3.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 3.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.4 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 1.5 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.7 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 2.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 1.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.9 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 9.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.2 | GO:0004938 | adrenergic receptor activity(GO:0004935) alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 1.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.6 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 1.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 2.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 2.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.6 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.1 | 0.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.4 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 0.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 6.2 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 5.6 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 6.2 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.6 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.2 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.0 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 30.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.3 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 1.0 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.3 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 3.3 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 1.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.5 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.1 | GO:0008443 | 6-phosphofructo-2-kinase activity(GO:0003873) phosphofructokinase activity(GO:0008443) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.0 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 5.1 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.0 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.4 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 1.2 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 1.2 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.5 | GO:0070405 | ammonium ion binding(GO:0070405) |
0.0 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.5 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.6 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.0 | 0.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 13.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.3 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.1 | 48.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.9 | 0.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.8 | 12.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 34.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.6 | 17.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 4.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 6.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 18.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 71.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 10.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 0.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 11.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 7.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 7.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 4.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 6.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 3.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 2.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 0.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 1.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 5.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 1.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 10.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 1.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 9.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 5.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 4.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 3.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 53.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 2.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 3.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 4.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 9.0 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 3.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 1.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 5.8 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.2 | 1.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 4.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 1.4 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 4.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 2.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 20.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 32.6 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.1 | 1.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 19.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.3 | 1.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
1.1 | 59.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.0 | 2.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.8 | 22.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.8 | 18.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.8 | 12.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.8 | 10.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.7 | 16.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 17.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.6 | 22.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 1.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.5 | 5.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.5 | 0.5 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.5 | 9.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 10.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 4.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 8.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 1.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 6.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.5 | 10.4 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.5 | 0.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 3.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 6.8 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.4 | 2.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 3.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 2.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 4.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 0.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 2.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 3.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.3 | 4.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 3.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 3.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 2.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 3.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 6.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 3.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 3.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 1.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 3.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 2.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 1.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 2.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 1.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 1.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 2.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 4.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 6.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 2.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 2.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 0.2 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 3.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 1.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 1.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 3.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 1.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 2.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 1.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 6.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 3.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.6 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 3.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 9.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 2.3 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 2.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 1.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 6.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 3.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.7 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |
0.1 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 1.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 2.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.7 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |